BFRA - Biofrontera AG

NasdaqCM - NasdaqCM Real-time price. Currency in USD
+0.69 (+5.26%)
As of 10:21AM EDT. Market open.
Stock chart is not supported by your current browser
Previous close13.17
Bid13.89 x 3000
Ask14.17 x 2000
Day's range13.86 - 13.86
52-week range11.25 - 17.98
Avg. volume6,595
Market cap324.246M
PE ratio (TTM)N/A
EPS (TTM)-0.96
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est20.83
Trade prices are not sourced from all markets
  • GlobeNewswire2 months ago

    Biofrontera files lawsuit against W.K.T. Zours, Deutsche Balaton AG and further defendants

    Leverkusen, Germany, June 12, 2018-- Biofrontera AG, an international biopharmaceutical company, today announced that it has filed a complaint in the United States District Court for the Southern District ...

  • GlobeNewswire3 months ago

    Biofrontera Reports First Quarter 2018 Financial Results

    Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its financial results for the first quarter ended March 31, 2018 and provided an update on recent operational and clinical developments. “We entered 2018 with a strong presence in the U.S. achieving record revenue increase and successfully completing an initial public offering on the Nasdaq Capital Market. Combined with a preemptive rights offering in Germany, Biofrontera raised €21.6 million in net proceeds that will support our expansion opportunities.

  • We're sorry, but this is all we were able to find on this topic.